Loading
Latest filing published 26 Oct 2009 for Stem Cell Therapy International, Inc., €1,103.
No signal scores available.
Thuy-Van Chau is a declared insider of Stem Cell Therapy International, Inc., with filings sourced from SEC (Form 4). Activity is concentrated on a single trading day, 16 September 2009, with 2 filings.
On the market, this insider has only sold: 2 sales, €2,223 in total.
The record was last updated on 26 October 2009 with an open-market sale (€1,103) in Stem Cell Therapy International, Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations